Emma Kilgallon of West Pharmaceutical Services bagged both the Overall Leader Award and the Best HR Leadership award at the Women in Pharma Awards 2026, recognised for a standard of leadership that has delivered measurable transformation within her organisation while extending her influence across the wider pharmaceutical sector.
The Overall Leader Award placed Kilgallon among the most distinguished recipients the Women in Pharma Awards confers, while the Best HR Leadership recognition brought a sharper focus to the measurable results her work has delivered over the past twelve months.
On the Overall Leader Award, judges stated: "An exceptional leader whose influence extends across both organisation and industry, Emma Kilgallon has consistently demonstrated a commitment to excellence, innovation, and meaningful progress. Her ability to lead with clarity and purpose has driven impactful outcomes while elevating those around her.”
“She is a strong advocate for inclusion and development, shaping pathways for future talent. Through strategic vision and authentic leadership, she has helped position her organisation at the forefront of the sector. Her contribution reflects the very highest standards of leadership and lasting impact."
On the Best HR Leadership award, the panel added: "Emma Kilgallon's career progression and impact showcase her as a high-performing HR leader driving meaningful transformation within the organisation. Over the past twelve months, her leadership has delivered clear, measurable results, as reflected in a well-structured and engaging submission.”
“Her contributions at a national level, alongside strong testimonials, enhanced her profile even more. This is a powerful example of HR leadership, with both significant internal impact and wider influence."
The Women in Pharma Awards 2026 ceremony took place on 29 April 2026 at the Crowne Plaza Hotel, Santry.
For the complete 2026 winners list, category details, and updates, visit the official Women in Pharma Awards website and subscribe to the newsletter for insights and coverage from Ireland's pharmaceutical community.




.png)

